88 related articles for article (PubMed ID: 1649960)
21. Tumor necrosis factor-alpha responses are depressed and interleukin-6 responses unaltered in feline immunodeficiency virus infected cats.
Ma J; Kennedy-Stoskopf S; Sellon R; Tonkonogy S; Hawkins EC; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 1995 May; 46(1-2):35-50. PubMed ID: 7618260
[TBL] [Abstract][Full Text] [Related]
22. In vitro properties and experimental pathogenic effect of three strains of feline immunodeficiency viruses (FIV) isolated from cats with terminal disease.
Moraillon A; Barré-Sinoussi F; Parodi A; Moraillon R; Dauguet C
Vet Microbiol; 1992 Apr; 31(1):41-54. PubMed ID: 1377438
[TBL] [Abstract][Full Text] [Related]
23. Feline immunodeficiency virus replicates in salivary gland ductular epithelium during the initial phase of infection.
Park HS; Kyaw-Tanner M; Thomas J; Robinson WF
Vet Microbiol; 1995 Sep; 46(1-3):257-67. PubMed ID: 8545964
[TBL] [Abstract][Full Text] [Related]
24. Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.
Choi IS; Hokanson R; Collisson EW
J Virol; 2000 Jan; 74(2):676-83. PubMed ID: 10623729
[TBL] [Abstract][Full Text] [Related]
25. Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies.
Tozzini F; Matteucci D; Bandecchi P; Baldinotti F; Poli A; Pistello M; Siebelink KH; Ceccherini-Nelli L; Bendinelli M
J Virol Methods; 1992 Jun; 37(3):241-52. PubMed ID: 1321834
[TBL] [Abstract][Full Text] [Related]
26. The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation.
Matteucci D; Mazzetti P; Baldinotti F; Zaccaro L; Bendinelli M
Vet Immunol Immunopathol; 1995 May; 46(1-2):71-82. PubMed ID: 7618261
[TBL] [Abstract][Full Text] [Related]
27. Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines.
Yamamoto JK; Ackley CD; Zochlinski H; Louie H; Pembroke E; Torten M; Hansen H; Munn R; Okuda T
Intervirology; 1991; 32(6):361-75. PubMed ID: 1657826
[TBL] [Abstract][Full Text] [Related]
28. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats.
Song W; Collisson EW; Billingsley PM; Brown WC
J Virol; 1992 Sep; 66(9):5409-17. PubMed ID: 1323704
[TBL] [Abstract][Full Text] [Related]
29. Current thoughts on feline immunodeficiency virus infection.
Sparger EE
Vet Clin North Am Small Anim Pract; 1993 Jan; 23(1):173-91. PubMed ID: 8380656
[TBL] [Abstract][Full Text] [Related]
30. Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat.
Siebelink KH; Chu IH; Rimmelzwaan GF; Weijer K; Osterhaus AD; Bosch ML
J Virol; 1992 Feb; 66(2):1091-7. PubMed ID: 1309891
[TBL] [Abstract][Full Text] [Related]
31. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
32. Biological nature of feline immunodeficiency virus.
Miyazawa T; Mikami T
J Vet Med Sci; 1993 Aug; 55(4):519-26. PubMed ID: 8399727
[TBL] [Abstract][Full Text] [Related]
33. Isolation of feline syncytia-forming virus from oropharyngeal swab samples and buffy coat cells.
Shroyer EL; Shalaby MR
Am J Vet Res; 1978 Apr; 39(4):555-60. PubMed ID: 646192
[TBL] [Abstract][Full Text] [Related]
34. [FIV: no death sentence ABCD: "Don't put a cat down just because she is FIV positive!" ].
Schweiz Arch Tierheilkd; 2008 Jul; 150(7):375-6. PubMed ID: 18714943
[No Abstract] [Full Text] [Related]
35. Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction.
Matteucci D; Baldinotti F; Mazzetti P; Pistello M; Bandecchi P; Ghilarducci R; Poli A; Tozzini F; Bendinelli M
J Clin Microbiol; 1993 Mar; 31(3):494-501. PubMed ID: 8384624
[TBL] [Abstract][Full Text] [Related]
36. Measurement of reverse transcriptase of feline immunodeficiency virus by poly A-linked colorimetric assay.
Saito T; Suzuki K; Imai M; Inaba Y
J Vet Med Sci; 1997 Jun; 59(6):425-9. PubMed ID: 9234215
[TBL] [Abstract][Full Text] [Related]
37. In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells.
Tochikura TS; Hayes KA; Cheney CM; Tanabe-Tochikura A; Rojko JL; Mathes LE; Olsen RG
Virology; 1990 Nov; 179(1):492-7. PubMed ID: 1699355
[TBL] [Abstract][Full Text] [Related]
38. 8-Difluoromethoxy-4-quinolone derivatives as anti-feline immunodeficiency virus (FIV) agents: important structural features for inhibitory activity of FIV replication.
Kashiwase H; Katsube T; Kimura T; Nishigaki T; Yamashita M
J Vet Med Sci; 2000 May; 62(5):499-504. PubMed ID: 10852398
[TBL] [Abstract][Full Text] [Related]
39. Encephalitis associated with giant cells in a cat with naturally occurring feline immunodeficiency virus infection demonstrated by in situ hybridization.
Gunn-Moore DA; Pearson GR; Harbour DA; Whiting CV
Vet Pathol; 1996 Nov; 33(6):699-703. PubMed ID: 8952030
[TBL] [Abstract][Full Text] [Related]
40. Mycological findings in feline immunodeficiency virus-infected cats.
Mancianti F; Giannelli C; Bendinelli M; Poli A
J Med Vet Mycol; 1992; 30(3):257-9. PubMed ID: 1325555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
